These data further support the notion that loss of Kindlin-2 in the mammary glands contributes to the inhibition of tumor growth in the primary site, and support a critical role of Kindlin-2, not only in the cancer cells but also in the epithelial cells of the mammary gland in tumor development. The gene discussed is FERMT2; the disease is cancer.